MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $411,172 | -57.9% | 33,079 | -52.5% | 0.00% | -50.0% |
| Q1 2023 | $976,231 | -46.6% | 69,681 | +8.4% | 0.00% | 0.0% |
| Q2 2022 | $1,827,000 | +27.5% | 64,305 | +58.3% | 0.00% | +100.0% |
| Q1 2022 | $1,433,000 | -41.3% | 40,628 | -30.3% | 0.00% | -50.0% |
| Q4 2021 | $2,443,000 | +38.0% | 58,289 | +61.7% | 0.00% | +100.0% |
| Q3 2021 | $1,770,000 | -2.7% | 36,048 | -17.4% | 0.00% | -50.0% |
| Q2 2021 | $1,820,000 | -92.9% | 43,620 | -93.9% | 0.00% | -92.0% |
| Q1 2021 | $25,475,000 | -18.6% | 714,807 | -36.0% | 0.02% | -19.4% |
| Q4 2020 | $31,314,000 | – | 1,116,350 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |